The massive use of antibiotics against anthrax can lead to emergence of super-virus, a strain of anthrax that is resistant to treatment with currently known remedies.

The U.S. government, in order to prevent an epidemic of anthrax, purchased in large quantities antibiotic Cipro (ciprofloxacin). Tens of thousands of U.S. citizens take this medicine as a preventive treatment. However, unjustified administration of powerful antibiotics develops “immunity” in many pathogenic viruses, and the same could happen with anthrax. In addition, under such conditions increases the likelihood of the possibility of purposeful development of a form of anthrax resistant to medicines that threatens a catastrophe.

Currently in clinical practice are becoming more common so-called respiratory fluoroquinolones, which on one hand, preserve the activity of the early fluoroquinolones (eg ciprofloxacin) against gram-negative organisms, but on the other – are more active against pneumococci and atypical bacteria.

Levofloxacin, the active component of Levaquin, is the most studied substance among respiratory fluoroquinolones. It has been prescribed to more than 300 million patients worldwide. A number of clinical studies has confirmed Levaquin’s high efficacy and safety both in the traditional indications for this group of antibiotics, such as acute sinusitis, exacerbation of chronic bronchitis, community-acquired pneumonia, urinary tract infections, and in some other diseases: nosocomial pneumonia, chronic bacterial prostatitis.

BanLec - a lectin represents a protein which is able to bind to sugars. Banana lectin is able to suppress HIV infection, preventing the penetration of the virus into the body. According to scientists, BanLec affects the protein shell that surrounds the genetic material of the HIV virus.

However, the main problem of HIV consists in virus mutation making HIV virus resistant to drugs. According to the study the presence of lectins makes difficult for the viruses to mutate.

Pneumonia in children

The effectiveness of treatment and options of initial therapy of community-acquired pneumonia in children

The optimum effect of the treatment

An effective antibiotic, not requiring the replacement should be considered one on the background of which within 24-48 hours (with uncomplicated pneumonia) and 72 hours (complicated):

• the temperature drops to normal or subfebril
• the general condition is improving;
• respiration rate and heart rate decrease.